22.01.2015 Views

6th International Workshop on Breast Densitometry and Breast ...

6th International Workshop on Breast Densitometry and Breast ...

6th International Workshop on Breast Densitometry and Breast ...

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

P21<br />

6 th <str<strong>on</strong>g>Internati<strong>on</strong>al</str<strong>on</strong>g> <str<strong>on</strong>g>Workshop</str<strong>on</strong>g> <strong>on</strong> <strong>Breast</strong> <strong>Densitometry</strong><br />

<strong>and</strong> <strong>Breast</strong> Cancer Risk Assessment<br />

MAMMOGRAPHIC DENSITY PHENOTYPES AND RISK OF BREAST CANCER: A<br />

META-ANALYSIS<br />

Andreas Petterss<strong>on</strong> 1 , Rebecca E. Graff 1 , Laura Baglietto 2, 3 , Marije F. Bakker 4 , Norman Boyd 5 , KeeSeng<br />

Chia 6 , Kamila Czene 7 , Isabel dos Santos Silva 8 , Louise Erikss<strong>on</strong> 7 , Graham G. Giles 2, 3, 9 , Per Hall 7 , Mikael<br />

Hartman 6, 7, 9 , John L. Hopper 3 , Kavitha Krishnan 2, 3 , Jingmei Li 11 , Qing Li 5 , Gertraud Maskarinec 12 ,<br />

Valerie McCormack 13 , Ian Pagano 12 , Bernard A. Rosner 14, 15 , Christopher Scott 16 , Jennifer St<strong>on</strong>e 3 , Giske<br />

Ursin 17, 18 , Celine Vach<strong>on</strong> 16 , Carla H. van Gils 4 , Chia Si<strong>on</strong>g W<strong>on</strong>g 6 1, 14<br />

, Rulla M. Tamimi<br />

1) Department of Epidemiology, Harvard School of Public Health, Bost<strong>on</strong>, MA, USA; 2) Cancer<br />

Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia; 3) Centre for Molecular,<br />

Envir<strong>on</strong>mental, Genetic <strong>and</strong> Analytical Epidemiology, The University of Melbourne, Australia; 4) Julius<br />

Center for Health Sciences <strong>and</strong> Primary Care, University Medical Center, Utrecht, The Netherl<strong>and</strong>s;<br />

5) Campbell Family Institute for <strong>Breast</strong> Cancer Research, Ontario Cancer Institute, Tor<strong>on</strong>to, Ontario,<br />

Canada; 6) Saw Swee Hock School of Public Health, Nati<strong>on</strong>al University of Singapore, Nati<strong>on</strong>al<br />

University Health System, Singapore; 7) Department of Medical Epidemiology <strong>and</strong> Biostatistics,<br />

Karolinska Institutet, Stockholm, Sweden; 8) Department of N<strong>on</strong>-Communicable Disease Epidemiology,<br />

L<strong>on</strong>d<strong>on</strong> School of Hygiene <strong>and</strong> Tropical Medicine, L<strong>on</strong>d<strong>on</strong>, United Kingdom; 9) Department of<br />

Epidemiology <strong>and</strong> Preventive Medicine, M<strong>on</strong>ash University, Melbourne, Australia; 10) Department of<br />

Surgery, Y<strong>on</strong>g Loo Lin School of Medicine, Nati<strong>on</strong>al University of Singapore, Singapore; 11) Human<br />

Genetics Divisi<strong>on</strong>, Genome Institute of Singapore, Singapore; 12) Department of Epidemiology, University<br />

of Hawaii Cancer Center, H<strong>on</strong>olulu, HI, USA; 13) Secti<strong>on</strong> of Envir<strong>on</strong>ment <strong>and</strong> Radiati<strong>on</strong>, <str<strong>on</strong>g>Internati<strong>on</strong>al</str<strong>on</strong>g><br />

Agency for Research <strong>on</strong> Cancer, Ly<strong>on</strong>, France; 14) Channing Divisi<strong>on</strong> of Network Medicine, Department<br />

of Medicine, Brigham <strong>and</strong> Women’s Hospital <strong>and</strong> Harvard Medical School, Bost<strong>on</strong>, MA, USA;<br />

15) Department of Biostatistics, Harvard School of Public Health, Bost<strong>on</strong>, MA, USA; 16) Department of<br />

Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, USA; 17) Department of<br />

Nutriti<strong>on</strong>, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway; 18) Department of<br />

Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA<br />

Background: Fibrogl<strong>and</strong>ular breast tissue appears dense <strong>on</strong> mammogram; fat appears n<strong>on</strong>dense. We<br />

investigated whether absolute or percent dense area more str<strong>on</strong>gly predicts breast cancer risk, <strong>and</strong> whether<br />

absolute n<strong>on</strong>dense area is independently associated with risk.<br />

Methods: We c<strong>on</strong>ducted a meta-analysis of 13 case-c<strong>on</strong>trol studies, each having provided parameter<br />

estimates <strong>and</strong> st<strong>and</strong>ard errors from logistic regressi<strong>on</strong>s for associati<strong>on</strong>s between <strong>on</strong>e st<strong>and</strong>ard deviati<strong>on</strong><br />

(SD) increments in mammographic density phenotypes <strong>and</strong> breast cancer risk. We used r<strong>and</strong>om-effects<br />

models to calculate pooled odds ratios (ORs) <strong>and</strong> 95% c<strong>on</strong>fidence intervals (CIs).<br />

ABSTRACTS<br />

Results: Am<strong>on</strong>g premenopausal women (1,776 cases; 2,834 c<strong>on</strong>trols), summary ORs for <strong>on</strong>e SD<br />

increments were 1.37 (95% CI: 1.29-1.47) for absolute dense area, 0.78 (95% CI: 0.71-0.86) for absolute<br />

n<strong>on</strong>dense area, <strong>and</strong> 1.52 (95% CI: 1.39-1.66) for percent dense area when pooling estimates adjusted for<br />

age, BMI <strong>and</strong> parity. Corresp<strong>on</strong>ding ORs am<strong>on</strong>g postmenopausal women (6,643 cases; 11,187 c<strong>on</strong>trols)<br />

were 1.38 (95% CI: 1.31-1.44), 0.79 (95% CI: 0.73-0.85), <strong>and</strong> 1.53 (95% CI: 1.44-1.64). After additi<strong>on</strong>al<br />

adjustment for absolute dense area, associati<strong>on</strong>s between absolute n<strong>on</strong>dense area <strong>and</strong> breast cancer<br />

became attenuated or null in several studies <strong>and</strong> summary ORs became 0.82 (95% CI: 0.71-0.94; P-<br />

heterogeneity: 0.02) for premenopausal <strong>and</strong> 0.85 (95% CI: 0.75-0.96; P-heterogeneity:

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!